Peripartum Cardiomyopathy: Clinical Trials

14 trials for Peripartum Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 unknown, 2 recruiting, 2 withdrawn. 2 Phase 2, 2 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 1, Withdrawn 1
Phase 42Completed 1, Recruiting 1

Follow Peripartum Cardiomyopathy: new trials by email Literature Review of Peripartum Cardiomyopathy trials Research Report on Peripartum Cardiomyopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.
Molecular and genetic screening - Peripartum Cardiomyopathy
UnknownFederico II University402024-02-212024-03-21
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT) - Peripartum Cardiomyopathy, Postpartum
Phase 4RecruitingDennis M. McNamara, MD, MS2502022-07-272026-08-10
Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.
Peripartum Cardiomyopathy
UnknownSohag University452021-02-202022-01-19
PPCM Observational Study (Peripartum Cardiomyopathy)
Clinical placement of a temporary IMPELLA® mechanical circulatory support device. - Peripartum Cardiomyopathy, Cardiogenic Shock
CompletedMedical College of Wisconsin1502021-01-112026-02-23
Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery
A clinical Transthoracic echocardiogram - Peripartum Cardiomyopathy, Diastolic Dysfunction
WithdrawnMedical College of Wisconsin2019-11-012024-08-23
"Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Extracorporeal Membrane Oxygenation - Cardiogenic Shock, Peripartum Cardiomyopathy
CompletedSarah Thordsen52019-10-282020-11-23
NT-proBNP Levels and Obesity in Pregnancy
NT-proBNP - Obesity, Pregnancy Complications
CompletedDuke University562019-07-152020-08-05
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.
Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation, Support treatment, cardiac medical treatment, aetiology-specific treatment - Non-ischemic Cardiomyopathy, Dilated Cardiomyopathy (DCM)
RecruitingScientific Institute San Raffaele150002018-01-302024-09-23
A Registry of Peripartum Cardiomyopathy in Turkey
Peripartum Cardiomyopathy
UnknownEge University502017-07-022017-12-06
Peripartum Cardiomyopathy in Nigeria Registry
Oral Sodium Selenite 200 µg/day for 3 months - Peripartum Cardiomyopathy
Phase 4CompletedAminu Kano Teaching Hospital1002017-06-122021-01-22
Bromocriptine in the Treatment of Peripartum Cardiomyopathy
Bromocriptine, Guideline-driven medical therapy (GDMT) - Peripartum Cardiomyopathy
Phase 3WithdrawnMontreal Heart Institute2017-01-012023-04-04
Taurine in Peripartum Cardiomyopathy
Taurine Solution, Normal Saline - Peripartum Cardiomyopathy
Phase 2 / Phase 3CompletedAin Shams University402015-01-012020-01-28
Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy
Bromocriptine - Peripartum Cardiomyopathy
Phase 2CompletedHannover Medical School642010-06-012020-09-07
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
Cardiomyopathy, Pregnancy-Associated Cardiomyopathy
UnknownSt. Vincent's Medical Center1752005-10-012006-05-26

Narrower conditions

Pregnancy Complications (3)  ·  Heart Failure (2)  ·  Shock, Cardiogenic (2)  ·  Arrhythmogenic Right Ventricular Dysplasia (1)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Dilated (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cardiomyopathy, Restrictive (1)  ·  Death, Sudden, Cardiac (1)  ·  Fabry Disease (1)  ·  Myocarditis (1)  ·  Obesity (1)  ·  Tachycardia, Ventricular (1)  ·  Ventricular Fibrillation (1)

Broader conditions

Cardiovascular Diseases (14)  ·  Female Urogenital Diseases and Pregnancy Complications (14)  ·  Heart Diseases (14)  ·  Pregnancy Complications, Cardiovascular (14)  ·  Urogenital Diseases (14)  ·  Cardiomyopathies (13)  ·  Pregnancy Complications (11)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (3)  ·  Vascular Diseases (3)  ·  Infarction (2)  ·  Ischemia (2)  ·  Myocardial Infarction (2)  ·  Myocardial Ischemia (2)  ·  Necrosis (2)

Interventions

Bromocriptine (3)  ·  Equipment and Supplies (1)  ·  Extracorporeal Membrane Oxygenation (1)  ·  Genetic Testing (1)  ·  Rivaroxaban (1)  ·  Saline Solution (1)  ·  Sodium Selenite (1)

Sponsors

Medical College of Wisconsin (2)  ·  Ain Shams University (1)  ·  Aminu Kano Teaching Hospital (1)  ·  Dennis M. McNamara, MD, MS (1)  ·  Duke University (1)  ·  Ege University (1)  ·  Federico II University (1)  ·  Hannover Medical School (1)  ·  Montreal Heart Institute (1)  ·  Sarah Thordsen (1)  ·  Scientific Institute San Raffaele (1)  ·  Sohag University (1)  ·  St. Vincent's Medical Center (1)

Countries

United States (6)  ·  Egypt (2)  ·  Italy (2)  ·  Canada (1)  ·  Germany (1)  ·  Nigeria (1)  ·  Turkey (Türkiye) (1)

Top investigators

Sarah Thordsen, MD (3)  ·  Anique Ducharme, MD FRCPC (1)  ·  Cezar Staniloae, MD, FACC (1)  ·  Chad A Grotegut, MD, MBA (1)  ·  Cinzia Perrino, MD pHD (1)  ·  Denise Hilfiker-Kleiner, Prof. Dr. (1)  ·  Dennis McNamara (1)  ·  Dilek Ural, MD (1)  ·  Guillaume Marquis-Gravel, MD, MSc (1)  ·  Johann Bauersachs, Prof. Dr. (1)  ·  Jordan G Safirstein, MD (1)  ·  Kamilu M Karaye, PhD (1)  ·  Maxime Tremblay-Gravel, MD, MSc (1)  ·  Olivier Desplantie, MD CM, FRCPC (1)  ·  Paolo Della Bella, MD (1)

Results publications

PMID 26026286, PMID 28934837, PMID 30051292, PMID 33087055, PMID 33397290, PMID 34247489, PMID 35973801, PMID 36202537, PMID 36745273, PMID 40914510

NIH funding

UG3HL153847 (1)